Valion Bio (VBIO) Net Margin Growth (1y) (2022 - 2026)
Valion Bio (VBIO) Net Margin Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.52 Bn | 132.67 Bn | 2.84 Bn | -185.00 |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.55 Bn | 3.93 Bn | -763.00 |
| 3 | Argenx Se | 65.31 Bn | 60.13 Bn | 1.37 Bn | 529.00 |
| 4 | Moderna | 61.77 Bn | 56.64 Bn | 52.00 Mn | 4,168.00 |
| 5 | BeOne Medicines | 42.26 Bn | 37.16 Bn | 1.53 Bn | 673.00 |
| 6 | Alnylam Pharmaceuticals | 31.19 Bn | 27.88 Bn | 992.69 Mn | 2,208.00 |
| 7 | BioNTech SE | 28.71 Bn | 10.31 Bn | 668.28 Mn | -1,652.00 |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 29,636.00 |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - | -392.00 |
| 10 | Valion Bio | 441,427.63 | -1.76 Mn | -45,000.00 | 213,345.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.78 Mn |
| Dec 31, 2025 | 93,014.00 |
| Sep 30, 2025 | -56,223.00 |
| Jun 30, 2025 | -130,169.00 |
| Mar 31, 2025 | -169,275.00 |
| Dec 31, 2024 | -19,575.00 |
| Sep 30, 2024 | -49,352.00 |
| Jun 30, 2024 | 40,503.00 |
| Mar 31, 2024 | 11,738.00 |
| Dec 31, 2023 | -7,770.00 |
| Sep 30, 2023 | -9,000.00 |
| Jun 30, 2023 | -77,111.00 |
| Mar 31, 2023 | -5,270.00 |
| Dec 31, 2022 | 2,376.00 |
| Sep 30, 2022 | -10,852.00 |
| Jun 30, 2022 | -10,419.00 |
| Mar 31, 2022 | -10,355.00 |